← Leaderboards

Ly James Lee

Ohio State University

Google Scholar ↗PubMed ↗ORCID ↗

$3,875,706

Attributed

$8,557,547

Total exposure

10

Grants

6

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY2007–22

$2.5M$1.9M$1.3M$625K$0

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$8,557,547 · 10

By mechanism

U01$2,664,982 · 1

R21$2,286,612 · 6

U18$1,778,969 · 1

R33$1,588,359 · 1

R43$238,625 · 1

Top collaborators

Most similar at Ohio State University

Same institution · by research overlap

Jonathan P. Godbout$8,921,077
Kalpana Ghoshal$5,864,666
Daniel J Wozniak$19,868,004
Sashwati Roy$8,043,268
John F Sheridan$19,868,269

Others in their field

Top investigators on “Cells”

Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
Barton F Haynes · Duke University$457,457,619
David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
Dennis R. Burton · Scripps Research Institute$278,781,854
Mary M Horowitz · Medical College Of Wisconsin$237,383,608

Research focus

CellsBaseTechnologyMicrornasNanotechnologyBiochipDoctor Of PhilosophyNanoparticleMessenger RnaDetectionMolecularSamplingOhioDesignBody FluidsPlasmaBloodBlood CirculationLiquid SubstanceResearch PersonnelCostBiological MarkersCancer DetectionCancer Patient

Grant awards (22)

Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies$878,950

U18 · FY2022 · TR

Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies$900,019

U18 · FY2021 · TR

Extracellular Vesicles in Small Cell Lung Cancer Early Detection$496,494

U01 · FY2021 · CA

Extracellular Vesicles in Small Cell Lung Cancer Early Detection$492,386

U01 · FY2020 · CA

Nucleic Acid Loaded Neutrophils as Therapeutics in Lupus$171,600

R21 · FY2020 · AR

Extracellular Vesicles in Small Cell Lung Cancer Early Detection$469,149

U01 · FY2019 · CA

Nucleic Acid Loaded Neutrophils as Therapeutics in Lupus$205,920

R21 · FY2019 · AR

Extracellular Vesicles in Small Cell Lung Cancer Early Detection$593,585

U01 · FY2018 · CA

Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis$238,625

R43 · FY2018 · CA · contact PI

Molecular Beacon Based Extracellular mRNA and Protein Detection for Early Cancer Diagnosis$1,588,359

R33 · FY2017 · CA · contact PI

Extracellular Vesicles in Small Cell Lung Cancer Early Detection$613,368

U01 · FY2017 · CA

Tethered Cationic Lipoplex Nanoparticle Assay for Liver Cancer Detection and Surv$159,393

R21 · FY2015 · CA · contact PI

Large Scale Nanochannel Electroporation (NEP) for Cell Reprogramming$198,383

R21 · FY2014 · EB · contact PI

Plasma RNA based Early Lung Cancer Detection by Tethered Cationic Lipoplex Assay$194,941

R21 · FY2014 · CA · contact PI

Tethered Cationic Lipoplex Nanoparticle Assay for Liver Cancer Detection and Surv$193,200

R21 · FY2014 · CA · contact PI

Large Scale Nanochannel Electroporation (NEP) for Cell Reprogramming$17,674

R21 · FY2014 · EB · contact PI

Large Scale Nanochannel Electroporation (NEP) for Cell Reprogramming$230,313

R21 · FY2013 · EB · contact PI

Plasma RNA based Early Lung Cancer Detection by Tethered Cationic Lipoplex Assay$167,022

R21 · FY2013 · CA · contact PI

Therapeutic delivery of anti-miR oligos to hepatocellular cancer$165,844

R21 · FY2012 · CA

Therapeutic delivery of anti-miR oligos to hepatocellular cancer$199,013

R21 · FY2011 · CA

Novel Micro/nanofluidic Electroporation Devices for DNA&Oligonucleotide Delivery$206,173

R21 · FY2008 · EB · contact PI

Novel Micro/nanofluidic Electroporation Devices for DNA&Oligonucleotide Delivery$177,136

R21 · FY2007 · EB · contact PI